AstraZeneca PLC (AZN)
92.51
-0.01
(-0.01%)
USD |
NASDAQ |
Dec 30, 16:00
92.00
-0.51
(-0.55%)
After-Hours: 20:00
AstraZeneca EPS Diluted (Quarterly): 0.8065 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GSK Plc | 1.323 |
| Amgen, Inc. | 5.934 |
| Gilead Sciences, Inc. | 2.434 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Bicycle Therapeutics Plc | -0.8476 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.520B |
| Revenue (Quarterly) | 15.10B |
| Total Expenses (Quarterly) | 12.58B |
| Enterprise Value | 311.36B |
| Gross Profit Margin (Quarterly) | 73.89% |
| Profit Margin (Quarterly) | 16.69% |
| Earnings Yield | 3.26% |
| Operating Earnings Yield | 4.40% |
| Normalized Earnings Yield | 3.323 |